Disposable Aseptic Isolation Systems Market Trends

Growth Drivers

• Increase in Bio Pharmacy Industry – As per IFPMA 23 biopharmaceutical companies, in July 2020 partnered with non-governmental stakeholders to develop 4 novel antibiotics by launching USD 1 billion AMR (Anti-Microbial Resistance) Action Fund.

• Rising Use of Vaccines- According to Our World in Data 67.4% of the world population has received one dose of the COVID-19 vaccine. Globally, 12.47 billion doses have been administered and 5.05 million are now being administered each day.

• Increase in Research Labs - As per aggregate estimates of about 60 companies, the investment of the private sector for R&D dedicated to AMR-related products was more than USD 2 billion in 2018.

• Rise of COVID-19 – The COVID-19 vaccine output reached about 13 billion doses by the end of 2021 and is estimated to reach 25 billion by mid-2022.

• Increase Deaths from Contaminated Products – Nitrosamines, potent carcinogens are found as an impurity in medications such as ranitidine, nizatidine, ARBs, metformin, and other OTC drugs.

Challenges

• Higher Purchase Costs – Current health expenditure across the world was 10 (% of GDP) in 2019, up from 9 in 2017.
• Limited Flexibility
• Lack of Sanitation Awareness in Low-Income Countries – According to a report by UNICEF, in 2020, 2.3 billion lack basic sanitation services.

The global disposable aseptic isolation systems market is segmented and analyzed for demand and supply by end-user into pharmaceutical companies, hospitals, chemical industry, research institutes, biosafety laboratories, and others. Out of which, the pharmaceutical companies segment is anticipated to hold the largest market size by the end of 2031 on account of growing demand for pharmaceutical isolators in the pharmaceutical and biotechnological industries during the forecast period. Moreover, the increasing regulations, usage of aseptic methods, growing research laboratories, cost of noncompliance, rising usage of harmful materials, and advancements in the efficiency of isolators are expected to be major growth factors. The research and development expenditure (in GDP %) in 2021 amounted to 2.63% up from 2.13% in 2017.